Biotrial has completed its acquisition of Warnex Bioanalytical Services Division and has launched BBS, Biotrial Bioanalytical Services. The acquisition expands Biotrial’s drug development services to international clients, providing access to the full spectrum of bioanalytical services to support preclinical and clinical development, including generics product development.   The acquisition brings a team of experts including a staff of more than 70, more than 250 validated assays, and 25,000-sq....